{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:30:21Z","timestamp":1778567421243,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.bpg.2007.01.006","type":"journal-article","created":{"date-parts":[[2007,6,4]],"date-time":"2007-06-04T13:07:21Z","timestamp":1180962441000},"page":"485-501","source":"Crossref","is-referenced-by-count":2,"title":["The patient with refractory diarrhoea"],"prefix":"10.1016","volume":"21","author":[{"given":"Michael J.G.","family":"Farthing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2007.01.006_bib1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00042737-199602000-00013","article-title":"Chronic diarrhoea: current concepts on mechanisms and management","volume":"8","author":"Farthing","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2007.01.006_bib2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s11894-005-0003-3","article-title":"Functional diarrhea","volume":"7","author":"Farthing","year":"2005","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.bpg.2007.01.006_bib3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00042737-200012060-00005","article-title":"Dilutional diarrhoea: under-diagnosed and over-investigated","volume":"12","author":"Pollok","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2007.01.006_bib4","unstructured":"Farthing MJG. Clinical presentation of diarrhoea in disorders of bowel function. In."},{"key":"10.1016\/j.bpg.2007.01.006_bib5","unstructured":"Farthing MJG, Cevallos AM, & Kelly MP. Intestinal protozoa. In Cook GC, Saunders WB (eds). Manson's Tropical Diseases. London; 1996, pp. 1255\u20131298."},{"key":"10.1016\/j.bpg.2007.01.006_bib6","unstructured":"Kelly MP, Amadi B & Farthing MJG. Parasitic and fungal infections. In Pediatric Gastrointestinal Disease, 4th edn. Hamilton: BC Decker Inc; 2006, In press."},{"key":"10.1016\/j.bpg.2007.01.006_bib7","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/gast.2002.33579","article-title":"Activation of the mucosal immune system in irritable bowel syndrome","volume":"122","author":"Chadwick","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2007.01.006_bib8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0016-5085(79)80054-2","article-title":"Screening for steatorrhea","volume":"77","author":"Luk","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2007.01.006_bib9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0035-9203(90)90386-S","article-title":"The relative merits of faecal and duodenal juice microscopy in the diagnosis of giardiasis","volume":"84","author":"Goka","year":"1990","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.bpg.2007.01.006_bib10","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1111\/j.1365-2036.2006.02913.x","article-title":"Systematic review: microscopic colitis","volume":"23","author":"Nyhlin","year":"2006","journal-title":"Aliment Pharmacol Therap"},{"key":"10.1016\/j.bpg.2007.01.006_bib11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3109\/00365529609006766","article-title":"A double-blind placebo-controlled trial with loperamide in irritable bowel syndrome","volume":"31","author":"Efskind","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2007.01.006_bib12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-133-2-200007180-00013","article-title":"Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials","volume":"133","author":"Jaiwala","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2007.01.006_bib13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2036.1994.tb00322.x","article-title":"Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome","volume":"8","author":"Poynard","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2007.01.006_bib14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1365-2036.2001.00937.x","article-title":"Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome","volume":"15","author":"Poynard","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2007.01.006_bib15","series-title":"Basic Mechanisms of Digestive Diseases: the Rationale for Clinical Management and Prevention","first-page":"59","article-title":"Irritable bowel syndrome: new drugs and therapeutic horizons","author":"Farthing","year":"2002"},{"key":"10.1016\/j.bpg.2007.01.006_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00003495-199856010-00002","article-title":"New drugs in the management of the irritable bowel syndrome","volume":"56","author":"Farthing","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.bpg.2007.01.006_bib17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/bega.1999.0040","article-title":"Irritable bowel syndrome: new pharmaceutical approaches to treatment","volume":"13","author":"Farthing","year":"1999","journal-title":"Bailliere's Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2007.01.006_bib18","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(00)02033-X","article-title":"Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial","volume":"355","author":"Camilleri","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2007.01.006_bib19","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1001\/archinte.161.14.1733","article-title":"A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome","volume":"161","author":"Camilleri","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bpg.2007.01.006_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1572-0241.2005.40365.x","article-title":"A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS","volume":"100","author":"Chang","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2007.01.006_bib21","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1111\/j.1572-0241.2000.03368.x","article-title":"Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome","volume":"95","author":"Pimental","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2007.01.006_bib22","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/00042737-200110000-00004","article-title":"A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome","volume":"13","author":"Niedzielin","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2007.01.006_bib23","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2004.11.050","article-title":"Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles","volume":"128","author":"O'Mahoney","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2007.01.006_bib24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/089106001753341282","article-title":"Probiotics in the management of irritable bowel syndrome: a review of clinical trials","volume":"3","author":"Hamilton-Miller","year":"2001","journal-title":"Microbial Ecol Health Dis"},{"key":"10.1016\/j.bpg.2007.01.006_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2036.2003.01640.x","article-title":"Randomized, double-blind placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome","volume":"18","author":"Dunlop","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2007.01.006_bib26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/gut.28.4.423","article-title":"Hypnotherapy in severe irritable bowel syndrome; further experience","volume":"28","author":"Whorwell","year":"1987","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2007.01.006_bib27","first-page":"277","article-title":"Psychological treatments for irritable bowel syndrome: a critique of controlled treatment trials","volume":"91","author":"Talley","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2007.01.006_bib28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0002-9343(99)00299-5","article-title":"Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis","volume":"108","author":"Jackson","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.bpg.2007.01.006_bib29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/BF02063948","article-title":"Effect of a tricyclic anti-depressant on small intestinal motility in health and in diarrhea-predominant irritable bowel syndrome","volume":"40","author":"Gorard","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2007.01.006_bib30","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/gut.35.4.496","article-title":"5 hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine uptake","volume":"34","author":"Gorard","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2007.01.006_bib31","first-page":"197","article-title":"Treatment of diabetic diarrhea with clonidine","volume":"101","author":"Fedorak","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2007.01.006_bib32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000201412","article-title":"The role of somatostatin analogues in the treatment of refractory diarrhoea","volume":"57","author":"Farthing","year":"1996","journal-title":"Digestion"},{"key":"10.1016\/j.bpg.2007.01.006_bib33","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1136\/gut.33.11.1578","article-title":"Effective treatment of diabetic diarrhoea with the somatostatin analogue, octreotide","volume":"33","author":"Mourad","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2007.01.006_bib34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1056\/NEJM198607103150203","article-title":"Clinical manifestations and therapy of Isospora belli infection in patients with AIDS","volume":"315","author":"De Hovitz","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2007.01.006_bib35","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0140-6736(97)07529-6","article-title":"Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy","volume":"351","author":"Carr","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2007.01.006_bib36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00002030-199801000-00005","article-title":"Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy","volume":"1","author":"Foudraine","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.bpg.2007.01.006_bib37","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/00002030-199811000-00026","article-title":"Decreased prevalence of intestinal cryptosporidiosis in HIV-infected patients concomitant to the widespread use of protease inhibitors","volume":"12","author":"Le Moing","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.bpg.2007.01.006_bib38","doi-asserted-by":"crossref","first-page":"637","DOI":"10.4269\/ajtmh.1997.56.637","article-title":"Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa","volume":"56","author":"Doumbo","year":"1997","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.bpg.2007.01.006_bib39","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0035-9203(98)90804-5","article-title":"A double-blind placebo controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico","volume":"92","author":"Rossignol","year":"1998","journal-title":"Trans R Soc Med"},{"key":"10.1016\/j.bpg.2007.01.006_bib40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1086\/321008","article-title":"Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of nitazoxanide","volume":"184","author":"Rossignol","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bpg.2007.01.006_bib41","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(02)11401-2","article-title":"Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomized controlled trial","volume":"360","author":"Amadi","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2007.01.006_bib42","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2036.2005.02394.x","article-title":"Nitazoxanide for persistent diarrhoea in Zambian acquired immune deficiency syndrome patients: a randomized-controlled trial","volume":"21","author":"Zulu","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2007.01.006_bib43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.7326\/0003-4819-101-2-202","article-title":"Treatment of intestinal cryptosporidiosis with spiramycin","volume":"101","author":"Portnoy","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2007.01.006_bib44","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/infdis\/160.2.342","article-title":"Spiramycin for treatment of Cryptosporidium enteritis","volume":"160","author":"Saez-Llorens","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bpg.2007.01.006_bib45","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/infdis\/159.1.131","article-title":"Spiramycin is not effective in treating Cryptosporidium diarrhea in infants: results of a double-blind randomized trial","volume":"159","author":"Wittenberg","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bpg.2007.01.006_bib46","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/jcp.51.2.138","article-title":"Chronic cryptosporidiosis in patients with AIDS: stable remission and possible eradication after long-term, low dose azithromycin","volume":"51","author":"Dionisio","year":"1998","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.bpg.2007.01.006_bib47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jac\/41.suppl_2.93","article-title":"Roxithromycin treatment of diarrhoea caused by Cryptosporidium spp. in patients with AIDS","volume":"41","author":"Uip","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bpg.2007.01.006_bib48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jac\/41.suppl_2.85","article-title":"AIDS-related cryptosporidial diarrhoea: an open study with roxithromycin","volume":"41","author":"Sprinz","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bpg.2007.01.006_bib49","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1136\/bmj.312.7040.1187","article-title":"Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomised double-blind controlled trial","volume":"312","author":"Kelly","year":"1996","journal-title":"Br Med J"},{"key":"10.1016\/j.bpg.2007.01.006_bib50","doi-asserted-by":"crossref","first-page":"A1007","DOI":"10.1016\/S0016-5085(98)84099-7","article-title":"Eradication of intracellular protozoa in AIDS patients using high dose albendazole","volume":"114","author":"Kelly","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2007.01.006_bib51","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0140-6736(95)90868-4","article-title":"Placebo-controlled trial of co-trimoxazole for Cyclospora infections among travellers and foreign residents in Nepal","volume":"345","author":"Hoge","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2007.01.006_bib52","doi-asserted-by":"crossref","first-page":"885","DOI":"10.7326\/0003-4819-132-11-200006060-00006","article-title":"Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients. A randomized, controlled trial","volume":"132","author":"Verdier","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2007.01.006_bib53","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4269\/ajtmh.2000.63.121","article-title":"Therapy for human gastrointestinal microsporidiosis","volume":"63","author":"Conteas","year":"2000","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.bpg.2007.01.006_bib54","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/01.inf.0000141724.06556.f9","article-title":"Albendazole therapy for Microsporidium diarrhea in immunocompetent Costa Rican children","volume":"23","author":"Tremoulet","year":"2004","journal-title":"Ped Inf Dis J"},{"key":"10.1016\/j.bpg.2007.01.006_bib55","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1056\/NEJMoa012924","article-title":"Fumagillin treatment of intestinal microsporidiosis","volume":"346","author":"Molina","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2007.01.006_bib56","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1080\/00365520310002210","article-title":"Incomplete remission with short-term prednisolone treatment in collagenous colitis: a randomized study","volume":"38","author":"Munck","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2007.01.006_bib57","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1053\/gast.2002.30295","article-title":"Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow up","volume":"122","author":"Baert","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2007.01.006_bib58","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/gut.52.2.248","article-title":"Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis","volume":"52","author":"Bonderup","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2007.01.006_bib59","first-page":"A880","article-title":"Randomized, double blind, placebo-controlled trial of bismuth subsalicylate for microscopic colitis","volume":"116","author":"Fine","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2007.01.006_bib60","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2036.2005.02624.x","article-title":"Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea","volume":"22","author":"Szajewska","year":"2005","journal-title":"Aliment Pharmacol Therap"},{"key":"10.1016\/j.bpg.2007.01.006_bib61","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S1542-3565(04)00677-9","article-title":"Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study","volume":"3","author":"Lewis","year":"2005","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691807000078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691807000078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T18:18:54Z","timestamp":1587579534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691807000078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S1521691807000078"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2007.01.006","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}